Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Assunto principal
Intervalo de ano de publicação
1.
Medicina (B Aires) ; 73(5): 482-94, 2013.
Artigo em Espanhol | MEDLINE | ID: mdl-24152410

RESUMO

Fabry disease is an X-linked hereditary lysosomal storage disorder caused by deficiency of the enzyme alpha-galactosidase A. Knowledge about this disease, and its medical management, has made remarkable progress in the last decade, including the development of its specific treatment. This guide was developed by medical professionals from various specialties involved in the care of patients with Fabry disease. The discussion and analysis of the available scientific evidence, coupled with the experience of each of the participants, has allowed us to develop the concepts included in this guide in order to provide a useful tool for all professionals who care for patients with Fabry disease.


Assuntos
Doença de Fabry/diagnóstico , Doença de Fabry/terapia , Fatores Etários , Terapia de Reposição de Enzimas , Doença de Fabry/fisiopatologia , Feminino , Humanos , Masculino , Fatores de Tempo
2.
Medicina (B.Aires) ; 73(5): 482-494, oct. 2013. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-708540

RESUMO

La enfermedad de Fabry es un trastorno de almacenamiento lisosomal hereditario ligado al cromosoma X, ocasionado por el déficit de la enzima alfa galactosidasa A. El conocimiento sobre esta patología, y en particular su manejo médico, ha progresado notablemente en la última década, incluyendo el desarrollo de su tratamiento específico. La presente guía fue desarrollada por profesionales médicos de diversas especialidades involucrados en la atención de pacientes con enfermedad de Fabry. La discusión y análisis de las evidencias científicas disponibles, sumado a la experiencia de cada uno de los participantes, ha permitido desarrollar los conceptos vertidos en esta guía con el objetivo de brindar una herramienta útil para todos los profesionales que asisten a pacientes con enfermedad de Fabry.


Fabry disease is an X-linked hereditary lysosomal storage disorder caused by deficiency of the enzyme alpha-galactosidase A. Knowledge about this disease, and its medical management, has made remarkable progress in the last decade, including the development of its specific treatment. This guide was developed by medical professionals from various specialties involved in the care of patients with Fabry disease. The discussion and analysis of the available scientific evidence, coupled with the experience of each of the participants, has allowed us to develop the concepts included in this guide in order to provide a useful tool for all professionals who care for patients with Fabry disease.


Assuntos
Feminino , Humanos , Masculino , Doença de Fabry/diagnóstico , Doença de Fabry/terapia , Fatores Etários , Terapia de Reposição de Enzimas , Doença de Fabry/fisiopatologia , Fatores de Tempo
3.
Medicina (B.Aires) ; 73(5): 482-494, oct. 2013. ilus, tab
Artigo em Espanhol | BINACIS | ID: bin-130303

RESUMO

La enfermedad de Fabry es un trastorno de almacenamiento lisosomal hereditario ligado al cromosoma X, ocasionado por el déficit de la enzima alfa galactosidasa A. El conocimiento sobre esta patología, y en particular su manejo médico, ha progresado notablemente en la última década, incluyendo el desarrollo de su tratamiento específico. La presente guía fue desarrollada por profesionales médicos de diversas especialidades involucrados en la atención de pacientes con enfermedad de Fabry. La discusión y análisis de las evidencias científicas disponibles, sumado a la experiencia de cada uno de los participantes, ha permitido desarrollar los conceptos vertidos en esta guía con el objetivo de brindar una herramienta útil para todos los profesionales que asisten a pacientes con enfermedad de Fabry.(AU)


Fabry disease is an X-linked hereditary lysosomal storage disorder caused by deficiency of the enzyme alpha-galactosidase A. Knowledge about this disease, and its medical management, has made remarkable progress in the last decade, including the development of its specific treatment. This guide was developed by medical professionals from various specialties involved in the care of patients with Fabry disease. The discussion and analysis of the available scientific evidence, coupled with the experience of each of the participants, has allowed us to develop the concepts included in this guide in order to provide a useful tool for all professionals who care for patients with Fabry disease.(AU)


Assuntos
Feminino , Humanos , Masculino , Doença de Fabry/diagnóstico , Doença de Fabry/terapia , Fatores Etários , Terapia de Reposição de Enzimas , Doença de Fabry/fisiopatologia , Fatores de Tempo
4.
Medicina (B Aires) ; 73(5): 482-94, 2013.
Artigo em Espanhol | BINACIS | ID: bin-132897

RESUMO

Fabry disease is an X-linked hereditary lysosomal storage disorder caused by deficiency of the enzyme alpha-galactosidase A. Knowledge about this disease, and its medical management, has made remarkable progress in the last decade, including the development of its specific treatment. This guide was developed by medical professionals from various specialties involved in the care of patients with Fabry disease. The discussion and analysis of the available scientific evidence, coupled with the experience of each of the participants, has allowed us to develop the concepts included in this guide in order to provide a useful tool for all professionals who care for patients with Fabry disease.


Assuntos
Doença de Fabry/diagnóstico , Doença de Fabry/terapia , Fatores Etários , Terapia de Reposição de Enzimas , Doença de Fabry/fisiopatologia , Feminino , Humanos , Masculino , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...